Recent studies have reinforced concerns over the use of cannabis during pregnancy, with evidence linking prenatal exposure to adverse cognitive and behavioral outcomes in children. Given increasing social acceptance and legalization of marijuana, there is a growing need for public awareness about the risks involved in using cannabis during pregnancy. The latest research published in *JAMA Pediatrics* emphasizes this, showing that children exposed to cannabis in the womb may suffer from poor executive functioning and aggressive behavior by age five. Organizations such as the American College of Obstetricians and Gynecologists (ACOG) have issued clear guidelines against cannabis use during pregnancy, and this new study strengthens the rationale behind these recommendations.
Key Findings from the Recent Study
The study in *JAMA Pediatrics* followed 250 children who were exposed to cannabis in utero, comparing their development to peers with no cannabis exposure. Results revealed that, at age five, children exposed to cannabis scored approximately 0.4 standard deviations lower in measures of attention and inhibitory control. These skills, collectively referred to as executive functions, are crucial for problem-solving, impulse control, and overall cognitive processing. The study utilized the NIH Toolbox Early Childhood Cognitive Composite to gauge these areas, ensuring a reliable measurement of developmental differences.
One key aspect of the study’s methodology was its use of propensity score weighting and adjustment for confounding variables such as socioeconomic status, education levels, and other environmental factors. These adjustments allow researchers to isolate cannabis exposure as a significant factor in the cognitive and behavioral differences observed. According to Dr. Katherine DePeau-Wilson, a lead researcher, the findings align with existing clinical recommendations from ACOG and underline the potential harm that cannabis can cause to fetal development.
Potential Mechanisms Behind Cannabis-Related Developmental Risks
The detrimental impact of cannabis on a developing fetus likely stems from how cannabis affects brain development. The main psychoactive component in cannabis, tetrahydrocannabinol (THC), crosses the placental barrier and can affect the endocannabinoid system, which plays a critical role in neurodevelopment. This system regulates processes like cell proliferation, differentiation, and communication in the fetal brain. Interference from THC during this sensitive time can disrupt these processes, leading to long-term developmental challenges.
One of the primary areas impacted by THC is the prefrontal cortex, a region responsible for executive functioning, attention, and self-control. Exposure to THC during pregnancy can interfere with the formation of neural networks within this region, resulting in delayed cognitive and behavioral development. The aggression observed in children exposed to cannabis prenatally may stem from the impaired inhibitory control associated with prefrontal cortex dysfunction.
Behavioral and Cognitive Challenges in Cannabis-Exposed Children
Executive function encompasses skills essential for managing thoughts, emotions, and actions. Deficits in executive function can manifest as impulsivity, poor decision-making, and challenges with goal-directed behavior. For children exposed to cannabis in utero, these difficulties can contribute to social and academic challenges. At age five, executive function is critical as children start formal schooling, where they are expected to pay attention, follow instructions, and interact cooperatively with peers. Impairments in these areas can lead to frustration and difficulties in adapting to structured environments.
Aggressive behavior, as noted in the study, is also a concern. Aggression at a young age can lead to social issues, difficulty forming friendships, and a higher likelihood of disciplinary actions. In the long term, poor executive function and aggressive tendencies can increase a child’s risk for mental health disorders, including anxiety and depression, as well as issues related to self-esteem.
Broader Implications for Long-Term Development
While this study focused on children at age five, research suggests that the effects of prenatal cannabis exposure may persist into adolescence and adulthood. Poor executive function and behavioral issues in childhood can contribute to difficulties in academic achievement, employment, and social relationships. Children with impaired executive function and impulse control are also at a higher risk for substance abuse and legal issues as they age. Thus, prenatal cannabis exposure has the potential to create a cycle of challenges that extend far beyond early childhood.
Clinical Recommendations and Public Health Implications
Organizations like ACOG have issued recommendations discouraging cannabis use during pregnancy, citing evidence that no amount of cannabis has been proven safe for fetal development. Despite these warnings, surveys suggest that a growing number of pregnant women view cannabis as a low-risk substance, partly due to its legal status in many areas and its use for treating pregnancy-related symptoms like nausea and insomnia. However, experts stress that alternative, safer treatments are available and should be considered instead.
Healthcare providers play a key role in educating patients about the risks associated with prenatal cannabis use. Given the findings from studies such as the one published in *JAMA Pediatrics*, there is a pressing need for prenatal counseling that includes clear guidance on avoiding cannabis. This includes addressing misconceptions about its safety and discussing potential risks for the child’s long-term development.
Addressing Myths and Misinformation
One of the challenges in reducing prenatal cannabis use is the persistence of myths surrounding its safety. Many people assume that because cannabis is a “natural” product, it poses little risk. Furthermore, some individuals mistakenly believe that cannabis is a safer alternative to prescribed medications during pregnancy. However, “natural” does not mean risk-free, particularly when it comes to fetal brain development.
Another common misconception is that cannabis may alleviate pregnancy-related anxiety and nausea without harmful effects. In reality, there are FDA-approved treatments for these symptoms that do not carry the same risks as cannabis. Pregnant individuals need access to this information to make informed choices for their own health and that of their developing child.
The recent study linking prenatal cannabis exposure to poor executive function and aggressive behavior in children adds to a growing body of evidence on the risks of using cannabis during pregnancy. Given that THC can cross the placental barrier and disrupt brain development, cannabis use during pregnancy can have lasting impacts on cognitive and behavioral outcomes for children. Healthcare providers, public health officials, and communities must work together to raise awareness about these risks and encourage safe, alternative treatments for managing pregnancy-related symptoms.
While further research is needed to understand the full extent of cannabis’s impact on fetal development, the findings underscore the importance of caution and adherence to existing medical guidelines. As legalization expands and social acceptance grows, it becomes even more crucial to prioritize maternal and child health through evidence-based recommendations. By increasing awareness and providing accurate information, society can help expectant mothers make the safest choices for themselves and their children.
- DePeau-Wilson, M. (2023, October 28). Researchers Observe Poor Executive Function, Aggressive Behavior At Age 5 Years Among Children Exposed To Cannabis During Pregnancy. MedPage Today. Retrieved from https://www.medpagetoday.com
- Thompson, D. (2023, October 28). Marijuana During Pregnancy Linked to Behavioral Problems in Children. HealthDay. Retrieved from https://www.healthday.com
- Gunn, J. K., Rosales, C. B., Center, K. E., Nunez, A., Gibson, S. J., Christ, C., & Ehiri, J. E. (2016). Prenatal exposure to cannabis and maternal and child health outcomes: a systematic review and meta-analysis. BMJ Open, 6(4), e009986. doi:10.1136/bmjopen-2015-009986.
- American College of Obstetricians and Gynecologists (ACOG). (2017). Marijuana Use During Pregnancy and Lactation. Committee Opinion No. 722. Retrieved from https://www.acog.org
- Wong, J. (2019, October 22). The Impact of Marijuana on the Developing Fetal Brain. Harvard Health Blog. Retrieved from https://www.health.harvard.edu
- Metz, T. D., & Stickrath, E. H. (2015). Marijuana use in pregnancy and lactation: A review of the evidence. American Journal of Obstetrics and Gynecology, 213(6), 761–778. doi:10.1016/j.ajog.2015.05.025.
- National Institute on Drug Abuse (NIDA). (2020). Marijuana Research Report: Is Marijuana Safe and Effective as Medicine? Retrieved from https://www.drugabuse.gov
El Camino Women’s Medical Group offers the latest Minimally Invasive Solutions for gynecologic problems. Drs. Amy Teng, Erika Balassiano, Pooja Gupta, Vanessa Dorismond, and Vivian Wan, all members of AAGL (American Association of Gynecologic Laparoscopy), are highly trained and experienced in the field of Minimally Invasive Gynecologic Surgery. Dr. Erika Balassiano has also completed a Minimally Invasive Gynecologic Surgery Fellowship under the supervision of world-renowned Dr. Camran Nezhat.
All of our physicians are El Camino Hospital doctors and operate and deliver at the Mountain View campus.
Serving Mountain View, Los Altos, Los Altos Hills, Atherton, Palo Alto, Redwood City, Burlingame, Saratoga, Cupertino, Sunnyvale, Los Gatos, Campbell, San Jose, Santa Clara, Silicon Valley, Milpitas, Fremont, South Bay, East Bay, and North Bay.